FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/083226 [Registered on: 24/03/2025] Trial Registered Prospectively
Last Modified On: 21/03/2025
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Comparison of three different modalities of treatment of ingrown toenail 
Scientific Title of Study   Comparison of 80% Trichloroacetic acid, 88% phenol and radiofrequency for matricectomy in treatment of ingrown toenail a prospective observational study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR MANASA KAYARKATTE NARAYAN 
Designation  Assistant Professor 
Affiliation  Department of Dermatology, Venereology and Leprosy, Kasturba Medical College, Mangalore 
Address  Department of Dermatology, Venereology and Leprosy, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka. India

Dakshina Kannada
KARNATAKA
575004
India 
Phone  09535625208  
Fax    
Email  drmanasakn@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR MANASA KAYARKATTE NARAYAN 
Designation  Assistant Professor 
Affiliation  Department of Dermatology, Venereology and Leprosy, Kasturba Medical College, Mangalore 
Address  Department of Dermatology, Venereology and Leprosy, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka. India

Dakshina Kannada
KARNATAKA
575004
India 
Phone  09535625208  
Fax    
Email  drmanasakn@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR MANASA KAYARKATTE NARAYAN 
Designation  Assistant Professor 
Affiliation  Department of Dermatology, Venereology and Leprosy, Kasturba Medical College, Mangalore 
Address  Department of Dermatology, Venereology and Leprosy, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka. India

Dakshina Kannada
KARNATAKA
575004
India 
Phone  09535625208  
Fax    
Email  drmanasakn@gmail.com  
 
Source of Monetary or Material Support  
Department of Dermatology, Venereology and Leprosy, Kasturba Medical College, Mangalore, Karnataka, India 575001 
 
Primary Sponsor  
Name  Kasturba Medical College Mangalore 
Address  Department of Dermatology, Venereology and Leprosy, Kasturba Medical College, Mangalore, Karnataka, India 575001 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Manasa Kayarkatte Narayan  Wenlock District Hospital  Govt wenlock hospital Mnagalore
Dakshina Kannada
KARNATAKA 
9535625208

drmanasakn@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethic Committee, Kasturba Medical College, Mangalore  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L600||Ingrowing nail,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  nil  nil 
Comparator Agent  nil  nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Adult patients suffering from ingrown toenail undergoing partial or complete nail avulsion with matricectomy 
 
ExclusionCriteria 
Details  Patients less than 18 years of age and patients planned for conservative management  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Pain during surgery
oozing after 1 day surgery
recurrence at 3 months 
day 0, 1 and 3 months
 
 
Secondary Outcome  
Outcome  TimePoints 
pain before surgery
demographic data 
at the time of recruitment 
 
Target Sample Size   Total Sample Size="48"
Sample Size from India="48" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   03/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Introduction:

Onychocryptosis or ingrown toenail is a common condition of the nail unit causing pain, discharge and infection. This causes significant impairment in quality of life. Hence treatment for this is essential.

The standard treatment now consists of nail avulsion with matricectomy. Matrix destruction can be done with cauterization with chemicals or physical destruction. Chemicals used can be trichloroacetic acid, phenol 88% or sodium hydroxide. Physical destructive modalities include surgery and more recently with radiofrequency, cryotherapy or ablative LASER.

 

Knowledge gap identified

There is a lack of study assessing the outcome comparing trichloroacetic acid 80%, phenol 88% and radiofrequency ablation of the matrix in onychocryptosis.Aim: To compare the outcome of 80% TCA, 88% phenol and radiofrequency for matricectomy in treatment of ingrown toe nail

  

Aim: To compare the outcome of 80% TCA, 88% phenol and radiofrequency for matricectomy in treatment of ingrown toe nail

Objectives:

1.     To study demographic and clinical features of ingrown toenail

2.     To assess the pain at baseline, pain and or side effects if any during procedure and post procedure following matricectomy in treatment of ingrown toenail

3.     To assess the recurrence rate amongst the three methods of matricectomy at 3months

Methodology:

a.     Study setting: Department of Dermatology, Venereology and Leprosy, Kasturba Medical College, Mangalore, Government Wenlock Hospital and KMC Attavar Hospital.

b.     Study design: Observational, prospective, institutional based study.

c.     Study participants: Consenting patients with ingrown toenail will be recruited from Government Wenlock Hospital and KMC Attavar Hospital, who fulfil the inclusion criteria. 

d.     Inclusion criteria: Adult patients suffering from ingrown toenail undergoing partial or complete nail avulsion with matricectomy.

e.     Exclusion criteria: Patients less than 18 years of age and patients planned for conservative management

f.      Study duration: Jan 2025 to Dec 2027 (2 year)

g.     Sample size: 48 (16 patients in each group). Assuming there will be a minimum difference of 0.5 in recurrence rate across three groups with 95% confidence interval and 80% power, the sample size was calculated as 16 in each group. The sample size was calculated using “Goodness of fit contingency tables” module in G power version 3.1.9.4.

h.     Sampling method: Purposive sampling

i.      Tool for data collection: Pre-validated proforma

j.      Data collection methodology: The patients undergoing treatment for ingrowth toenail with matricectomy will be recruited following informed consent. Pre-procedure photographs will be taken and saved in an anonymous manner. Patient demographic data will be collected and entered into the proforma. Pain will be assessed based on visual analogue scale. The dermatologist who refers the patient for the surgery will decide the type of matricectomy as per their clinical decision. The first 16 patients in each group will be collected by the operating dermatologist and categorized to group 1 (80% TCA), group 2 (88% Phenol) and group 3 (radiofrequency ablation) and will note any intraoperative difficulties or side effects, this data will be entered, and it will be coded and stored. Post procedure side-effect and long-term outcome at follow up which is usually done at 3 months, will also be noted. A photograph will be taken at this time and pre and post procedure photographs will be compared by the dermatologist.

k.     Outcome variables: Pain using visual analogue scale, rate of recurrence, ooze, erythema, pain and swelling, or tissue damage. Drainage/ooze will be graded as grade 0: no discharge, grade 1: minimal soakage of dressing with no visible discharge, grade 2: mild discharge on pressing the folds only, grade 3: discharge visible on the toe, and grade 4: excessive discharge. Recurrence if any will be graded with Mozena’s classification [2].

 

Biological materials required: None

 

Data analysis: Data will be entered into Microsoft Excel. Analysis will be done using SPSS version 29 (IBM Corp. Released 2023. IBM SPSS Statistics for Windows, Version 29.0.2.0 Armonk, NY: IBM Corp). Descriptive statistics for continuous variables will be presented as mean with standard deviation (SD) or median with interquartile range (IQR), while categorical variables will be summarized as frequency and percentage. Associations between two categorical variables will be tested using the chi-square test, and differences in pain across three groups will be analyzed using analysis of variance (ANOVA). P-value less than 0.05 will be considered statistically significant.

 

Implications: We will identify a safer and efficient method of matricectomy.

 
Close